Circulating PIWI-interacting RNAs in Acute Ischemic Stroke patients

Background: Stroke refers to an abrupt neurological deficit, caused by an acute focal injury of the central nervous system via infarction or hemorrhage due to impaired vascularity, and remains among the leading causes of disability and death worldwide. Stroke is often preceded by an episode of neuro...

Full description

Saved in:
Bibliographic Details
Main Authors: Salman M. Toor, Eman K. Aldous, Aijaz Parray, Naveed Akhtar, Yasser Al-Sarraj, Abdelilah Arredouani, Ghulam Jeelani Pir, Sajitha V. Pananchikkal, Omar El-Agnaf, Ashfaq Shuaib, Nehad M. Alajez, Omar M.E. Albagha
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2025-04-01
Series:Non-coding RNA Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468054025000174
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850195776083329024
author Salman M. Toor
Eman K. Aldous
Aijaz Parray
Naveed Akhtar
Yasser Al-Sarraj
Abdelilah Arredouani
Ghulam Jeelani Pir
Sajitha V. Pananchikkal
Omar El-Agnaf
Ashfaq Shuaib
Nehad M. Alajez
Omar M.E. Albagha
author_facet Salman M. Toor
Eman K. Aldous
Aijaz Parray
Naveed Akhtar
Yasser Al-Sarraj
Abdelilah Arredouani
Ghulam Jeelani Pir
Sajitha V. Pananchikkal
Omar El-Agnaf
Ashfaq Shuaib
Nehad M. Alajez
Omar M.E. Albagha
author_sort Salman M. Toor
collection DOAJ
description Background: Stroke refers to an abrupt neurological deficit, caused by an acute focal injury of the central nervous system via infarction or hemorrhage due to impaired vascularity, and remains among the leading causes of disability and death worldwide. Stroke is often preceded by an episode of neuronal deficit termed transient ischemic attack (TIA), which presents an effective opportunity for mitigating the risk of an eminent acute ischemic stroke (AIS). Circulating non-coding RNAs (ncRNAs) have emerged as important biomarkers for stroke, but PIWI-interacting RNAs (piRNAs), a class of small regulatory ncRNAs, have not been previously explored as diagnostic or prognostic biomarkers for stroke. Methods: We conducted comprehensive circulating piRNA profiling of AIS and TIA patients using RNA-seq on serum samples collected within 24 h of clinical diagnosis. The study cohort was divided into discovery and cross-validation datasets to identify replicated piRNAs using stringent analysis cut-offs. The expression levels of the panel of differentially regulated piRNAs between AIS and TIA patients were also compared with healthy controls. Results: We identified a panel of 10 differentially regulated piRNAs between AIS and TIA patients; hsa-piR-28272, -piR-32972, -piR-28247, -piR-24553, -piR-24552, -piR-28275, -piR-28707 and -piR-32882 were upregulated, while hsa-piR-23058 and -piR-23136 were downregulated in AIS patients. Moreover, these 10 piRNAs were also differentially expressed in AIS patients compared to healthy controls. In addition, we investigated the potential gene targets of the dysregulated piRNAs and their plausible involvement in pathophysiological processes affected in stroke. Conclusions: The imbalances in the circulating piRnome of AIS and TIA patients presented herein provide important insights into the roles of piRNAs following ischemic brain injury and potentially provide opportunities to mitigate stroke-induced mortality and morbidity.
format Article
id doaj-art-7b9037c553f64b19b4e1ff35319a8db8
institution OA Journals
issn 2468-0540
language English
publishDate 2025-04-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Non-coding RNA Research
spelling doaj-art-7b9037c553f64b19b4e1ff35319a8db82025-08-20T02:13:40ZengKeAi Communications Co., Ltd.Non-coding RNA Research2468-05402025-04-011129430210.1016/j.ncrna.2025.01.005Circulating PIWI-interacting RNAs in Acute Ischemic Stroke patientsSalman M. Toor0Eman K. Aldous1Aijaz Parray2Naveed Akhtar3Yasser Al-Sarraj4Abdelilah Arredouani5Ghulam Jeelani Pir6Sajitha V. Pananchikkal7Omar El-Agnaf8Ashfaq Shuaib9Nehad M. Alajez10Omar M.E. Albagha11College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O. Box 34110, Doha, Qatar; Corresponding authors. College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O. Box 34110, Doha, Qatar.College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O. Box 34110, Doha, QatarThe Neuroscience Institute, Academic Health System, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, QatarThe Neuroscience Institute, Academic Health System, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar; Department of Internal Medicine, University of Manitoba, MB R3A 1R9, Winnipeg, CanadaQatar Genome Program (QGP), Qatar Foundation Research, Development and Innovation, Qatar Foundation (QF), P.O. Box 5825, Doha, QatarCollege of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O. Box 34110, Doha, Qatar; Diabetes Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O. Box 34110, Doha, QatarThe Neuroscience Institute, Academic Health System, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, QatarThe Neuroscience Institute, Academic Health System, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, QatarNeurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O. Box 34110, Doha, QatarDivision of Neurology, Department of Medicine, University of Alberta, AB T6G 2R3, Edmonton, Canada; Department of Neurology, Hamad Medical Corporation (HMC), P.O. Box 5825, Doha, QatarCollege of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O. Box 34110, Doha, Qatar; Translational Oncology Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O. Box 34110, Doha, QatarCollege of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O. Box 34110, Doha, Qatar; Diabetes Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O. Box 34110, Doha, Qatar; Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, EH4 2XU, Edinburgh, UK; Corresponding authors. College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), P.O. Box 34110, Doha, Qatar.Background: Stroke refers to an abrupt neurological deficit, caused by an acute focal injury of the central nervous system via infarction or hemorrhage due to impaired vascularity, and remains among the leading causes of disability and death worldwide. Stroke is often preceded by an episode of neuronal deficit termed transient ischemic attack (TIA), which presents an effective opportunity for mitigating the risk of an eminent acute ischemic stroke (AIS). Circulating non-coding RNAs (ncRNAs) have emerged as important biomarkers for stroke, but PIWI-interacting RNAs (piRNAs), a class of small regulatory ncRNAs, have not been previously explored as diagnostic or prognostic biomarkers for stroke. Methods: We conducted comprehensive circulating piRNA profiling of AIS and TIA patients using RNA-seq on serum samples collected within 24 h of clinical diagnosis. The study cohort was divided into discovery and cross-validation datasets to identify replicated piRNAs using stringent analysis cut-offs. The expression levels of the panel of differentially regulated piRNAs between AIS and TIA patients were also compared with healthy controls. Results: We identified a panel of 10 differentially regulated piRNAs between AIS and TIA patients; hsa-piR-28272, -piR-32972, -piR-28247, -piR-24553, -piR-24552, -piR-28275, -piR-28707 and -piR-32882 were upregulated, while hsa-piR-23058 and -piR-23136 were downregulated in AIS patients. Moreover, these 10 piRNAs were also differentially expressed in AIS patients compared to healthy controls. In addition, we investigated the potential gene targets of the dysregulated piRNAs and their plausible involvement in pathophysiological processes affected in stroke. Conclusions: The imbalances in the circulating piRnome of AIS and TIA patients presented herein provide important insights into the roles of piRNAs following ischemic brain injury and potentially provide opportunities to mitigate stroke-induced mortality and morbidity.http://www.sciencedirect.com/science/article/pii/S2468054025000174Non-coding RNAPIWIpiRNAIschemicStrokeBiomarkers
spellingShingle Salman M. Toor
Eman K. Aldous
Aijaz Parray
Naveed Akhtar
Yasser Al-Sarraj
Abdelilah Arredouani
Ghulam Jeelani Pir
Sajitha V. Pananchikkal
Omar El-Agnaf
Ashfaq Shuaib
Nehad M. Alajez
Omar M.E. Albagha
Circulating PIWI-interacting RNAs in Acute Ischemic Stroke patients
Non-coding RNA Research
Non-coding RNA
PIWI
piRNA
Ischemic
Stroke
Biomarkers
title Circulating PIWI-interacting RNAs in Acute Ischemic Stroke patients
title_full Circulating PIWI-interacting RNAs in Acute Ischemic Stroke patients
title_fullStr Circulating PIWI-interacting RNAs in Acute Ischemic Stroke patients
title_full_unstemmed Circulating PIWI-interacting RNAs in Acute Ischemic Stroke patients
title_short Circulating PIWI-interacting RNAs in Acute Ischemic Stroke patients
title_sort circulating piwi interacting rnas in acute ischemic stroke patients
topic Non-coding RNA
PIWI
piRNA
Ischemic
Stroke
Biomarkers
url http://www.sciencedirect.com/science/article/pii/S2468054025000174
work_keys_str_mv AT salmanmtoor circulatingpiwiinteractingrnasinacuteischemicstrokepatients
AT emankaldous circulatingpiwiinteractingrnasinacuteischemicstrokepatients
AT aijazparray circulatingpiwiinteractingrnasinacuteischemicstrokepatients
AT naveedakhtar circulatingpiwiinteractingrnasinacuteischemicstrokepatients
AT yasseralsarraj circulatingpiwiinteractingrnasinacuteischemicstrokepatients
AT abdelilaharredouani circulatingpiwiinteractingrnasinacuteischemicstrokepatients
AT ghulamjeelanipir circulatingpiwiinteractingrnasinacuteischemicstrokepatients
AT sajithavpananchikkal circulatingpiwiinteractingrnasinacuteischemicstrokepatients
AT omarelagnaf circulatingpiwiinteractingrnasinacuteischemicstrokepatients
AT ashfaqshuaib circulatingpiwiinteractingrnasinacuteischemicstrokepatients
AT nehadmalajez circulatingpiwiinteractingrnasinacuteischemicstrokepatients
AT omarmealbagha circulatingpiwiinteractingrnasinacuteischemicstrokepatients